UBS AM’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.35M | Buy |
689,855
+253,938
| +58% | +$495K | ﹤0.01% | 2308 |
|
|
2025
Q1 | $767K | Buy |
435,917
+88,111
| +25% | +$155K | ﹤0.01% | 2406 |
|
|
2024
Q4 | $925K | Buy |
347,806
+122,187
| +54% | +$325K | ﹤0.01% | 2397 |
|
|
2024
Q3 | $517K | Sell |
225,619
-8,670
| -4% | -$19.9K | ﹤0.01% | 2636 |
|
|
2024
Q2 | $684K | Buy |
+234,289
| New | +$684K | ﹤0.01% | 2542 |
|
|
2023
Q4 | – | Sell |
-178,816
| Closed | -$240K | – | 2584 |
|
|
2023
Q3 | $240K | Hold |
178,816
| – | – | ﹤0.01% | 2477 |
|
|
2023
Q2 | $297K | Hold |
178,816
| – | – | ﹤0.01% | 2481 |
|
|
2023
Q1 | $297K | Buy |
178,816
+32,226
| +22% | +$53.5K | ﹤0.01% | 2481 |
|
|
2022
Q4 | $281K | Buy |
146,590
+4,216
| +3% | +$8.1K | ﹤0.01% | 2351 |
|
|
2022
Q3 | $319K | Sell |
142,374
-16,838
| -11% | -$37.7K | ﹤0.01% | 2481 |
|
|
2022
Q2 | $516K | Buy |
159,212
+28,996
| +22% | +$93.9K | ﹤0.01% | 2300 |
|
|
2022
Q1 | $685K | Hold |
130,216
| – | – | ﹤0.01% | 2331 |
|
|
2021
Q4 | $1.11M | Buy |
130,216
+41,231
| +46% | +$350K | ﹤0.01% | 2160 |
|
|
2021
Q3 | $885K | Hold |
88,985
| – | – | ﹤0.01% | 2230 |
|
|
2021
Q2 | $828K | Buy |
+88,985
| New | +$828K | ﹤0.01% | 2316 |
|